Cva Family Office, LLC Agios Pharmaceuticals, Inc. Transaction History
Cva Family Office, LLC
- $619 Million
- Q4 2024
A detailed history of Cva Family Office, LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 15 shares of AGIO stock, worth $516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$516
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
232Shares Held
58.1MCall Options Held
403KPut Options Held
469K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$195 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.55MShares$191 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$167 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$129 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$97.6 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.89B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...